{"schema_version":"1","generated_at":"2026-11-06T19:28:18.024Z","data_as_of":null,"url":"https://www.findmykol.com/kol/christopher-hourigan","json_url":"https://www.findmykol.com/kol/christopher-hourigan/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"christopher-hourigan","name":"Christopher Hourigan","credential":"MD, DPHIL","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Baltimore","state":"MD","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1124222468","orcid":"0000-0002-6189-8067","openalex":"A5061303658"},"summary":"Christopher Hourigan is an Oncology physician. OpenAlex indexes 259 publications with 11,361 citations (h-index 44); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":259,"cited_by_count":11361,"h_index":44,"source":"works"},"trials":{"count":1,"shown":3,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT05224661","title":"Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events","status":"TERMINATED","role":"Overall official","sponsor":"Center for International Blood and Marrow Transplant Research","source_url":"https://clinicaltrials.gov/study/NCT05224661","trial_url":"https://www.findmykol.com/trial/NCT05224661"},{"nct":"NCT02996474","title":"Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia","phase":"PHASE1/PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","source_url":"https://clinicaltrials.gov/study/NCT02996474","trial_url":"https://www.findmykol.com/trial/NCT02996474"},{"nct":"NCT02527447","title":"Biomarkers for Personalized Early Assessment of Response During Salvage Chemotherapy in People With Relapsed or Refractory Acute Myeloid Leukemia (PEARL15)","status":"COMPLETED","role":"Overall official","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","source_url":"https://clinicaltrials.gov/study/NCT02527447","trial_url":"https://www.findmykol.com/trial/NCT02527447"}],"source":"trials"},"payments":{"company_count":4,"program_years":{"first":2021,"last":null},"rows_total":4,"shown":3,"withheld":1,"rows":[{"payer":"Astellas","program_year":2025,"amount_usd":5075,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1124222468"},{"payer":"Syndax Pharmaceuticals","program_year":2025,"amount_usd":2932.17,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1124222468"},{"payer":"Janssen","program_year":2025,"amount_usd":1550,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1124222468"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1124222468","source":"payments"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":1}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}